0ILL.L
Laboratorios Farmacéuticos Rovi, S.A. is a Spanish pharmaceutical enterprise that specializes in the research, development, manufacturing, and global commercialization of its own medicinal products. The company's operations span Spain, the European Union, OECD countries, and various international markets. In addition to its proprietary portfolio, Rovi also distributes pharmaceutical products under license from other laboratories. Its comprehensive product range addresses diverse medical requirements. Key offerings include Hibor and Enoxaparin biosimilar Becat, both low-molecular-weight heparins vital for the prevention and management of venous thromboembolic disease. Neparvis is prescribed f...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-02-24
Stock Exchange
LSE
Ticker
0ILL.L
According to Laboratorios Farmaceuticos Rovi, S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 17.58. This represents a change of -59.38% compared to the average of 43.28 of the last 4 quarters.
The mean historical PE Ratio of Laboratorios Farmaceuticos Rovi, S.A. over the last ten years is 28.79. The current 17.58 PE Ratio has changed 6.01% with respect to the historical average. Over the past ten years (40 quarters), 0ILL.L's PE Ratio was at its highest in in the December 2017 quarter at 873.05. The PE Ratio was at its lowest in in the December 2022 quarter at 6.16.
Average
28.79
Median
25.14
Minimum
9.66
Maximum
49.95
Discovering the peaks and valleys of Laboratorios Farmaceuticos Rovi, S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.15%
Maximum Annual PE Ratio = 49.95
Minimum Annual Increase = -63.85%
Minimum Annual PE Ratio = 9.66
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 23.13 | -1.91% |
| 2024 | 23.58 | 28.73% |
| 2023 | 18.31 | 89.67% |
| 2022 | 9.66 | -63.85% |
| 2021 | 26.71 | -22.31% |
| 2020 | 34.38 | 0.28% |
| 2019 | 34.28 | -31.36% |
| 2018 | 49.95 | 11.60% |
| 2017 | 44.76 | 93.15% |
| 2016 | 23.17 | -35.83% |
The current PE Ratio of Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
21.67
5-year avg
20.28
10-year avg
28.79
Laboratorios Farmaceuticos Rovi, S.A.’s PE Ratio is greater than Vetoquinol S.A. (14.40), greater than Boiron S.A. (14.97), greater than Valneva SE (-2.84), greater than Nanobiotix S.A. (-59.96), greater than Inventiva S.A. (-5.64), greater than Formycon AG (-5.46), greater than Drägerwerk AG & Co. KGaA (10.40), greater than AB Science S.A. (-40.48), greater than Transgene S.A. (-3.20), greater than Vivoryon Therapeutics N.V. (-3.46),
| Company | PE Ratio | Market cap |
|---|---|---|
| 14.40 | N/A | |
| 14.97 | N/A | |
| -2.84 | N/A | |
| -59.96 | N/A | |
| -5.64 | N/A | |
| -5.46 | N/A | |
| 10.40 | N/A | |
| -40.48 | N/A | |
| -3.20 | N/A | |
| -3.46 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laboratorios Farmaceuticos Rovi, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Laboratorios Farmaceuticos Rovi, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Laboratorios Farmaceuticos Rovi, S.A.'s PE Ratio?
How is the PE Ratio calculated for Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)?
What is the highest PE Ratio for Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)?
What is the 3-year average PE Ratio for Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)?
What is the 5-year average PE Ratio for Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)?
How does the current PE Ratio for Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) compare to its historical average?